PATIENTEMPOWERED RESEARCH IN PROSTATE CANCER A consumer-led initiative within the Prostate Cancer Prognosis and Treatment Study (PRECEPT).
L
e a r n i n g t h a t yo u h ave c a n c e r c a n b e a confronting and frightening experience, and the variation in prostate cancer treatment options can be particularly confusing for men. How do men that were diagnosed with localized prostate cancer decide on a treatment? And how would biomarker information influence the decision-making process? These are questions consumers from the Victorian Comprehensive Cancer Centre (VCCC) and researchers from the University of Melbourne are tackling together as part of the PRostatE CancEr Prognosis and Treatment Study (PRECEPT).
Sophy Athan (top left), Dr Riccarda Peters (top right), Les Leckie (lower left), Keith Donohoe (lower right). 54 INSPIRE 021 | 2021
The PRostatE CancEr Prognosis and Treatment Study (PRECEPT), which was funded by the Prostate Cancer Research Alliance, a joint initiative between the Movember Foundation and the Australian Government, aims to improve care for patients with prostate cancer. PRECEPT